Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex
Minoru Tada(National Institute of Health Sciences), Akiko Ishii‐Watabe(National Institute of Health Sciences)
Cited by 5
Related Papers
Fcγ Receptor-Dependent Internalization and Off-Target Cytotoxicity of Antibody-Drug Conjugate Aggregates
|Pharmaceutical Research|2021|74
Fcγ Receptor Activation by Human Monoclonal Antibody Aggregates
|Journal of Pharmaceutical Sciences|2019|30